{
  "ticker": "LLY",
  "target_date": "2025-01-24",
  "actual_date": "2025-01-24",
  "collected_at": "2025-12-08T11:19:17.854563",
  "price": {
    "open": 756.31,
    "high": 783.45,
    "low": 754.86,
    "close": 779.5950927734375,
    "volume": 4170600,
    "change_1d_pct": 2.45,
    "change_7d_pct": 5.44,
    "change_30d_pct": -2.26
  },
  "technicals": {
    "rsi_14": 51.71,
    "sma_20": 765.55,
    "sma_50": 773.46,
    "macd": -7.614,
    "macd_signal": -8.852,
    "macd_histogram": 1.238,
    "bb_upper": 806.66,
    "bb_lower": 724.44,
    "price_vs_sma20_pct": 1.83,
    "price_vs_sma50_pct": 0.79,
    "volume_ratio": 1.16
  },
  "fundamentals": {
    "market_cap": 889760251904,
    "pe_ratio": 48.629597,
    "forward_pe": 43.800972,
    "price_to_book": 37.369354,
    "price_to_sales": 14.974137,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.74,
    "pct_from_52w_low": 59.12
  },
  "macro": {
    "spy": {
      "price": 602.69,
      "change_1d_pct": -0.29,
      "change_7d_pct": 2.56
    },
    "vix": {
      "level": 14.85,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.63
    },
    "dollar_index": {
      "level": 107.44
    },
    "gold": {
      "price": 2777.3
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms",
      "source": "DowJones",
      "datetime": 1737735426,
      "summary": "Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms",
      "url": "https://finnhub.io/api/news?id=fe221ce97276e6be8824900422af534ed79f47a1e23fbcfd197ae00334fb5db4"
    },
    {
      "headline": "Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk",
      "source": "DowJones",
      "datetime": 1737735306,
      "summary": "Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk",
      "url": "https://finnhub.io/api/news?id=a1f9023803096feaeb843786820cc7463ae012e4e2224be8cb663e23493e4b2c"
    },
    {
      "headline": "ETFs Have Come A Long Way",
      "source": "SeekingAlpha",
      "datetime": 1737721800,
      "summary": "Sylvia Jablonski,\u00c2\u00a0CEO and CIO of Defiance ETFs,\u00c2\u00a0shares why 2024 was such a great year of innovation for issuers\u00c2\u00a0and what's in store for 2025.",
      "url": "https://finnhub.io/api/news?id=cd328c4674876b9c5881b788f77f1db3ba6acb831b0961d1493dfe44025036e1"
    },
    {
      "headline": "Novo Nordisk Stock Soars on New Weight-Loss Drug Results",
      "source": "MarketWatch",
      "datetime": 1737713340,
      "summary": "Novo Nordisk Stock Soars on New Weight-Loss Drug Results",
      "url": "https://finnhub.io/api/news?id=f6fead1ab1f1901d3f15a90cba5dd2a06c96d9fc0d101128cd3c5c7a6a795768"
    },
    {
      "headline": "Wall Street Breakfast Podcast: Allurion Soars On Balloon And GLP-1 Study Plans",
      "source": "SeekingAlpha",
      "datetime": 1737700967,
      "summary": "Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI launches shopping agent Operator; Etsy, eBay tick higher.",
      "url": "https://finnhub.io/api/news?id=f8e50d276c47512d07f1a7e0c2988970b79dd674823a2b9930d4d844e2ffd475"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667469.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000016/xslF345X05/wk-form4_1737667469.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667411.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000014/xslF345X05/wk-form4_1737667411.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000012/xslF345X05/wk-form4_1737667361.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667303.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000010/xslF345X05/wk-form4_1737667303.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667237.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000008/xslF345X05/wk-form4_1737667237.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}